{"id":"NCT05223478","sponsor":"Ocuphire Pharma, Inc.","briefTitle":"Nyxol (0.75% Phentolamine Ophthalmic Solution) to Reverse Pharmacologically-Induced Mydriasis in Pediatric Subjects","officialTitle":"Randomized, Parallel Arm, Double-Masked, Placebo-Controlled Study of the Safety and Efficacy of Nyxol (0.75% Phentolamine Ophthalmic Solution) to Reverse Pharmacologically Induced Mydriasis in Healthy Pediatric Subjects","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2021-12-17","primaryCompletion":"2022-04-18","completion":"2022-04-28","firstPosted":"2022-02-04","resultsPosted":"2023-08-02","lastUpdate":"2023-09-05"},"enrollment":23,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Mydriasis","Dilation"],"interventions":[{"type":"DRUG","name":"Phentolamine Ophthalmic Solution 0.75%","otherNames":["NyxolÂ®","Nyxol"]},{"type":"DRUG","name":"Phentolamine Ophthalmic Solution Vehicle","otherNames":[]}],"arms":[{"label":"Phentolamine Ophthalmic Solution 0.75%","type":"ACTIVE_COMPARATOR"},{"label":"Phentolamine Ophthalmic Solution Vehicle","type":"PLACEBO_COMPARATOR"}],"summary":"The objectives of this study are:\n\n* To evaluate the safety of Nyxol in pediatric subjects\n* To evaluate the efficacy of Nyxol to expedite the reversal of pharmacologically induced mydriasis in pediatric subjects The Sponsor intends to use this study to evaluate Nyxol in pediatric subjects aged 3 to 11 for the indication \"the treatment of pharmacologically induced mydriasis produced by adrenergic (phenylephrine) or parasympatholytic (tropicamide) agents, or a combination thereof.\"","primaryOutcome":{"measure":"Safety Measurements","timeFrame":"0 Minutes, 90 Minutes, 3 Hours, 24 Hours","effectByArm":[{"arm":"Phentolamine Ophthalmic Solution 0.75%","deltaMin":0.3,"sd":0.65},{"arm":"Phentolamine Ophthalmic Solution Vehicle","deltaMin":-0.2,"sd":0.58}],"pValues":[]},"eligibility":{"minAge":"3 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":2,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":11},"commonTop":[]}}